These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38238757)
21. Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina. Zibbell JE; Peiper NC; Duhart Clarke SE; Salazar ZR; Vincent LB; Kral AH; Feinberg J Int J Drug Policy; 2021 Jul; 93():103128. PubMed ID: 33487527 [TBL] [Abstract][Full Text] [Related]
22. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting. McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056 [TBL] [Abstract][Full Text] [Related]
23. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs. Reed MK; Salcedo VJ; Guth A; Rising KL J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663 [TBL] [Abstract][Full Text] [Related]
25. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061 [TBL] [Abstract][Full Text] [Related]
26. Detecting fentanyl using point-of-care drug checking technologies: A validation study. Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280 [TBL] [Abstract][Full Text] [Related]
27. Perspectives on Fentanyl Test Strip Use among People Who Inject Drugs in Rural Appalachia. Allen ST; O'Rourke A; White RH; Sherman SG; Grieb SM Subst Use Misuse; 2020; 55(10):1594-1600. PubMed ID: 32336188 [No Abstract] [Full Text] [Related]
28. Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs. Bergh MS; Øiestad ÅML; Baumann MH; Bogen IL Int J Drug Policy; 2021 Apr; 90():103065. PubMed ID: 33333419 [TBL] [Abstract][Full Text] [Related]
29. Pilot testing fentanyl test strip distribution in an emergency department setting: Experiences, lessons learned, and suggestions from staff. Reed MK; Salcedo VJ; Hsiao T; Esteves Camacho T; Salvatore A; Siegler A; Rising KL Acad Emerg Med; 2023 Jun; 30(6):626-635. PubMed ID: 36333960 [TBL] [Abstract][Full Text] [Related]
30. Rapid Response to the Legalization of Fentanyl Test Strips in Alabama: An Academic-Community Partnership. McCollum CG; Ventrelli G; Gagnon KW; Loftis A; Famurewa A; Wimberly C; Eaton E Am J Public Health; 2024 Aug; 114(8):785-788. PubMed ID: 38870434 [TBL] [Abstract][Full Text] [Related]
31. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study. Park JN; Tomko C; Silberzahn BE; Haney K; Marshall BDL; Sherman SG Addict Behav; 2020 Nov; 110():106529. PubMed ID: 32683172 [TBL] [Abstract][Full Text] [Related]
32. North Carolina pharmacists' willingness to sell fentanyl test strips: a survey study. Marley GT; Ostrach B; Carpenter D Harm Reduct J; 2023 Jan; 20(1):10. PubMed ID: 36694186 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. Park JN; Frankel S; Morris M; Dieni O; Fahey-Morrison L; Luta M; Hunt D; Long J; Sherman SG Int J Drug Policy; 2021 Aug; 94():103196. PubMed ID: 33713964 [TBL] [Abstract][Full Text] [Related]
34. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs. Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227 [No Abstract] [Full Text] [Related]
35. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980 [TBL] [Abstract][Full Text] [Related]
36. Use of fentanyl test strips by people who inject drugs: Baseline findings from the South Atlantic Fentanyl Test Strip Study (SAFTSS). Zibbell JE; Aldridge A; Peiper N; Clarke SED; Rinderle A; Feinberg J Int J Drug Policy; 2024 Nov; 133():104588. PubMed ID: 39368231 [TBL] [Abstract][Full Text] [Related]
37. Costing analysis of a point-of-care drug checking program in Rhode Island. Cepeda JA; Thompson E; Ujeneza M; Tardif J; Walsh T; Morales A; Rosen JG; Green TC; Park JN Drug Alcohol Depend; 2023 Dec; 253():111028. PubMed ID: 38000322 [TBL] [Abstract][Full Text] [Related]
38. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry. Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332 [TBL] [Abstract][Full Text] [Related]
39. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants. Reed MK; Roth AM; Tabb LP; Groves AK; Lankenau SE Int J Drug Policy; 2021 Jun; 92():103147. PubMed ID: 33583679 [TBL] [Abstract][Full Text] [Related]
40. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin. Tilhou AS; Birstler J; Baltes A; Salisbury-Afshar E; Malicki J; Chen G; Brown R Harm Reduct J; 2022 Dec; 19(1):142. PubMed ID: 36522777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]